Demographic data, risk factors and clinical presentation in the total population
| Variable . | NoDM . | Non-ITDM . | ITDM . | P-value . |
|---|---|---|---|---|
| N = 985 . | N = 376 . | N = 186 . | ||
| Age (years) | 64.3 ± 10.5 | 63.8 ± 9.6 | 62.5 ± 10.3 | 0.082 |
| Age >65 years | 49.3% | 46% | 44.6% | 0.350 |
| Male sex at birth | 72.4% | 71.8% | 53.2% | <0.001* |
| Smoking history (any) | 56.2% | 55% | 47.8% | 0.112 |
| Current smoker | 24.1% | 22.2% | 13.9% | 0.011* |
| Hypertension | 73.9% | 91.2% | 96.2% | <0.001* |
| Hyperlipidaemia | 76.7% | 89% | 87.4% | <0.001 |
| Peripheral vascular disease | 7.1% | 10.4% | 16% | <0.001 |
| Congestive heart failure | 6.1% | 7.8% | 15.1% | <0.001* |
| Chronic renal insufficiency | 4.6% | 8.3% | 22.3% | <0.001* |
| Dialysis dependent | 0.5% | 8.7% | 1.9% | <0.001 |
| Previous myocardial infarction | 25.1% | 23.5% | 23.2% | 0.743 |
| Previous PCI | 45.2% | 44.7% | 49.5% | 0.526 |
| Body-mass index | 29.04 ± 5.78 | 31.26 ± 6.55 | 33.71 ± 7.1 | <0.001* |
| LDL cholesterol (mg/dL) | 95.6 ± 41.7 (n = 610) | 82.8 ± 35.6 (n = 251) | 85.8 ± 39.1 (n = 120) | <0.001 |
| Clinical presentation | ||||
| Stabilized STEMI | 2.6% | 2.1% | 2.2% | 0.827 |
| Non-STEMI | 24.2% | 27.1% | 27.4% | 0.410 |
| Unstable angina | 26.1% | 25.3% | 26.3% | 0.944 |
| Stable angina or positive stress test | 47.1% | 45.5% | 44.1% | 0.696 |
| Baseline medication usage | ||||
| Statin usage alone | 66.1% | 75.7% | 71.5% | 0.002 |
| Dual antiplatelet agent usage | 43.5% | 39.2% | 43.5% | 0.341 |
| Discharge medication usage | ||||
| Statin usage alone | 85.6% | 86.7% | 81.1% | 0.194 |
| Dual antiplatelet agent usage | 85.9% | 88% | 86.5% | 0.586 |
| Variable . | NoDM . | Non-ITDM . | ITDM . | P-value . |
|---|---|---|---|---|
| N = 985 . | N = 376 . | N = 186 . | ||
| Age (years) | 64.3 ± 10.5 | 63.8 ± 9.6 | 62.5 ± 10.3 | 0.082 |
| Age >65 years | 49.3% | 46% | 44.6% | 0.350 |
| Male sex at birth | 72.4% | 71.8% | 53.2% | <0.001* |
| Smoking history (any) | 56.2% | 55% | 47.8% | 0.112 |
| Current smoker | 24.1% | 22.2% | 13.9% | 0.011* |
| Hypertension | 73.9% | 91.2% | 96.2% | <0.001* |
| Hyperlipidaemia | 76.7% | 89% | 87.4% | <0.001 |
| Peripheral vascular disease | 7.1% | 10.4% | 16% | <0.001 |
| Congestive heart failure | 6.1% | 7.8% | 15.1% | <0.001* |
| Chronic renal insufficiency | 4.6% | 8.3% | 22.3% | <0.001* |
| Dialysis dependent | 0.5% | 8.7% | 1.9% | <0.001 |
| Previous myocardial infarction | 25.1% | 23.5% | 23.2% | 0.743 |
| Previous PCI | 45.2% | 44.7% | 49.5% | 0.526 |
| Body-mass index | 29.04 ± 5.78 | 31.26 ± 6.55 | 33.71 ± 7.1 | <0.001* |
| LDL cholesterol (mg/dL) | 95.6 ± 41.7 (n = 610) | 82.8 ± 35.6 (n = 251) | 85.8 ± 39.1 (n = 120) | <0.001 |
| Clinical presentation | ||||
| Stabilized STEMI | 2.6% | 2.1% | 2.2% | 0.827 |
| Non-STEMI | 24.2% | 27.1% | 27.4% | 0.410 |
| Unstable angina | 26.1% | 25.3% | 26.3% | 0.944 |
| Stable angina or positive stress test | 47.1% | 45.5% | 44.1% | 0.696 |
| Baseline medication usage | ||||
| Statin usage alone | 66.1% | 75.7% | 71.5% | 0.002 |
| Dual antiplatelet agent usage | 43.5% | 39.2% | 43.5% | 0.341 |
| Discharge medication usage | ||||
| Statin usage alone | 85.6% | 86.7% | 81.1% | 0.194 |
| Dual antiplatelet agent usage | 85.9% | 88% | 86.5% | 0.586 |
Values are % or mean ± standard deviation unless otherwise noted.
ITDM, insulin-treated diabetic patients; LDL, low-density lipoprotein; NoDM, non-diabetic patients; non-ITDM, non-insulin-treated diabetic patients.
Significant difference between non-ITDM and ITDM with a P < 0.05.
Demographic data, risk factors and clinical presentation in the total population
| Variable . | NoDM . | Non-ITDM . | ITDM . | P-value . |
|---|---|---|---|---|
| N = 985 . | N = 376 . | N = 186 . | ||
| Age (years) | 64.3 ± 10.5 | 63.8 ± 9.6 | 62.5 ± 10.3 | 0.082 |
| Age >65 years | 49.3% | 46% | 44.6% | 0.350 |
| Male sex at birth | 72.4% | 71.8% | 53.2% | <0.001* |
| Smoking history (any) | 56.2% | 55% | 47.8% | 0.112 |
| Current smoker | 24.1% | 22.2% | 13.9% | 0.011* |
| Hypertension | 73.9% | 91.2% | 96.2% | <0.001* |
| Hyperlipidaemia | 76.7% | 89% | 87.4% | <0.001 |
| Peripheral vascular disease | 7.1% | 10.4% | 16% | <0.001 |
| Congestive heart failure | 6.1% | 7.8% | 15.1% | <0.001* |
| Chronic renal insufficiency | 4.6% | 8.3% | 22.3% | <0.001* |
| Dialysis dependent | 0.5% | 8.7% | 1.9% | <0.001 |
| Previous myocardial infarction | 25.1% | 23.5% | 23.2% | 0.743 |
| Previous PCI | 45.2% | 44.7% | 49.5% | 0.526 |
| Body-mass index | 29.04 ± 5.78 | 31.26 ± 6.55 | 33.71 ± 7.1 | <0.001* |
| LDL cholesterol (mg/dL) | 95.6 ± 41.7 (n = 610) | 82.8 ± 35.6 (n = 251) | 85.8 ± 39.1 (n = 120) | <0.001 |
| Clinical presentation | ||||
| Stabilized STEMI | 2.6% | 2.1% | 2.2% | 0.827 |
| Non-STEMI | 24.2% | 27.1% | 27.4% | 0.410 |
| Unstable angina | 26.1% | 25.3% | 26.3% | 0.944 |
| Stable angina or positive stress test | 47.1% | 45.5% | 44.1% | 0.696 |
| Baseline medication usage | ||||
| Statin usage alone | 66.1% | 75.7% | 71.5% | 0.002 |
| Dual antiplatelet agent usage | 43.5% | 39.2% | 43.5% | 0.341 |
| Discharge medication usage | ||||
| Statin usage alone | 85.6% | 86.7% | 81.1% | 0.194 |
| Dual antiplatelet agent usage | 85.9% | 88% | 86.5% | 0.586 |
| Variable . | NoDM . | Non-ITDM . | ITDM . | P-value . |
|---|---|---|---|---|
| N = 985 . | N = 376 . | N = 186 . | ||
| Age (years) | 64.3 ± 10.5 | 63.8 ± 9.6 | 62.5 ± 10.3 | 0.082 |
| Age >65 years | 49.3% | 46% | 44.6% | 0.350 |
| Male sex at birth | 72.4% | 71.8% | 53.2% | <0.001* |
| Smoking history (any) | 56.2% | 55% | 47.8% | 0.112 |
| Current smoker | 24.1% | 22.2% | 13.9% | 0.011* |
| Hypertension | 73.9% | 91.2% | 96.2% | <0.001* |
| Hyperlipidaemia | 76.7% | 89% | 87.4% | <0.001 |
| Peripheral vascular disease | 7.1% | 10.4% | 16% | <0.001 |
| Congestive heart failure | 6.1% | 7.8% | 15.1% | <0.001* |
| Chronic renal insufficiency | 4.6% | 8.3% | 22.3% | <0.001* |
| Dialysis dependent | 0.5% | 8.7% | 1.9% | <0.001 |
| Previous myocardial infarction | 25.1% | 23.5% | 23.2% | 0.743 |
| Previous PCI | 45.2% | 44.7% | 49.5% | 0.526 |
| Body-mass index | 29.04 ± 5.78 | 31.26 ± 6.55 | 33.71 ± 7.1 | <0.001* |
| LDL cholesterol (mg/dL) | 95.6 ± 41.7 (n = 610) | 82.8 ± 35.6 (n = 251) | 85.8 ± 39.1 (n = 120) | <0.001 |
| Clinical presentation | ||||
| Stabilized STEMI | 2.6% | 2.1% | 2.2% | 0.827 |
| Non-STEMI | 24.2% | 27.1% | 27.4% | 0.410 |
| Unstable angina | 26.1% | 25.3% | 26.3% | 0.944 |
| Stable angina or positive stress test | 47.1% | 45.5% | 44.1% | 0.696 |
| Baseline medication usage | ||||
| Statin usage alone | 66.1% | 75.7% | 71.5% | 0.002 |
| Dual antiplatelet agent usage | 43.5% | 39.2% | 43.5% | 0.341 |
| Discharge medication usage | ||||
| Statin usage alone | 85.6% | 86.7% | 81.1% | 0.194 |
| Dual antiplatelet agent usage | 85.9% | 88% | 86.5% | 0.586 |
Values are % or mean ± standard deviation unless otherwise noted.
ITDM, insulin-treated diabetic patients; LDL, low-density lipoprotein; NoDM, non-diabetic patients; non-ITDM, non-insulin-treated diabetic patients.
Significant difference between non-ITDM and ITDM with a P < 0.05.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
